Protocolos de acceso expandido
de Parálisis Cerebral y Autismo
1/160 niños
en el mundo tienen autismo
1/300 nacidos vivos
tienen Parálisis Cerebral
1/45 nacidos prematuros
tienen Parálisis Cerebral
La Universidad de Duke en Octubre de 2017 lanzó el Primer programa de acceso ampliado con Células Madre de Sangre de Cordón Umbilical para Parálisis Cerebral y Autismo que permite a los niños con estos trastornos recibir el tratamiento con su propia unidad de Sangre de Cordón Umbilical.
Al ser un protocolo de acceso ampliado permite que un paciente con una enfermedad grave, que no ha encontrado una terapia eficaz para su condición, tenga la posibilidad de usar un producto médico que se ha demostrado que es seguro pero que no ha sido comercializado por el momento.
A través del convenio con FAMICORD nuestros clientes pueden acceder al programa de tratamiento de acceso ampliado basado en protocolo de la Universidad de Duke.
Ensayos Clínicos
El potencial de las Células Madre de Sangre de Cordón Umbilical en la medicina regenerativa están en constante estudio. Te mostramos las últimas novedades científicas.
| Código NCT | Categoría | Fases | Estatus | Localización | URL |
|---|---|---|---|---|---|
| NCT03735277 | Accidente Cerebro Vascular | Fase 1 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT03735277 |
| NCT03004976 | Accidente Cerebro Vascular | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT03004976 |
| NCT03913312 | Leucemia mieloide Aguda | Fase 1|Fase 2 | Reclutando | China | https://ClinicalTrials.gov/show/NCT03913312 |
| NCT03431480 | Síndrome del corazón izquierdo hipoplásico | Fase 1 | Reclutando | Australia | https://ClinicalTrials.gov/show/NCT03431480 |
| NCT01856049 | Síndrome del corazón izquierdo hipoplásico | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01856049 |
| NCT03441958 | Mieloma Múltiple | Fase 1|Fase 2 | Reclutando | Canadá | https://ClinicalTrials.gov/show/NCT03441958 |
| NCT01451502 | Trastorno linfático | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01451502 |
| NCT04172181 | SCID | N/A | Activo, no recluta | China | https://ClinicalTrials.gov/show/NCT04172181 |
| NCT04170192 | Enfermedad Inflamatoria Intestinal | N/A | Activo, no recluta | China | https://ClinicalTrials.gov/show/NCT04170192 |
| NCT04420494 | Citopenia | N/A | Reclutando | China | https://ClinicalTrials.gov/show/NCT04420494 |
| NCT03526588 | Enfermedad congénita | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03526588 |
| NCT01861093 | Anemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01861093 |
| NCT01861093 | Leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01861093 |
| NCT01861093 | Mielodisplasia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01861093 |
| NCT01861093 | Linfoma | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01861093 |
| NCT04243382 | Autismo | Fase 2 | No recluta aún | Israel | https://ClinicalTrials.gov/show/NCT04243382 |
| NCT04007224 | Autismo | Fase 1 | Solo con invitación | Rumania | https://ClinicalTrials.gov/show/NCT04007224 |
| NCT02551003 | Encefalopatía hipóxico-isquémica | Fase 1|Fase 2 | Reclutando | China | https://ClinicalTrials.gov/show/NCT02551003 |
| NCT02745717 | Anemia | Fase 4 | Reclutando | China | https://ClinicalTrials.gov/show/NCT02745717 |
| NCT02455830 | Encefalopatía hipóxico-isquémica | N/A | Activo, no recluta | Japon | https://ClinicalTrials.gov/show/NCT02455830 |
| NCT01553461 | Mielodisplasia | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01553461 |
| NCT01553461 | Anemia | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01553461 |
| NCT04440670 | Trastorno Mental | Fase 3 | No recluta aún | China | https://ClinicalTrials.gov/show/NCT04440670 |
| NCT03881774 | Linfoma | Fase 1 | Reclutando | China | https://ClinicalTrials.gov/show/NCT03881774 |
| NCT04243408 | Parálisis cerebral | Fase 2 | No recluta aún | Israel | https://ClinicalTrials.gov/show/NCT04243408 |
| NCT03696745 | Daño cerebral | Fase 1 | No recluta aún | China | https://ClinicalTrials.gov/show/NCT03696745 |
| NCT01768845 | Leucemia | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01768845 |
| NCT01768845 | Linfoma | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01768845 |
| NCT01768845 | Anemia | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01768845 |
| NCT01351545 | Leucemia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01351545 |
| NCT01351545 | Linfoma | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01351545 |
| NCT01351545 | Anemia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01351545 |
| NCT01351545 | Desorden del Sistema Inmune | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01351545 |
| NCT01351545 | Desorden Metabólico | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01351545 |
| NCT02103296 | Anemia | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02103296 |
| NCT01247701 | Trastornos Hematológicos | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01247701 |
| NCT00604201 | Mielodisplasia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00604201 |
| NCT00604201 | Anemia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00604201 |
| NCT00739141 | Leucemia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00739141 |
| NCT00739141 | Linfoma | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00739141 |
| NCT00739141 | Mielodisplasia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00739141 |
| NCT00950846 | Defecto congénito | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00950846 |
| NCT03913026 | Trastornos Hematológicos | Fase 2 | Reclutando | Canada | https://ClinicalTrials.gov/show/NCT03913026 |
| NCT02932826 | Diabetes Tipo 1 | Fase 1|Fase 2 | Reclutando | China | https://ClinicalTrials.gov/show/NCT02932826 |
| NCT01883076 | Síndrome del corazón izquierdo hipoplásico | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01883076 |
| NCT03473301 | Parálisis cerebral | Fase 1|Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT03473301 |
| NCT02433509 | Accidente Cerebro Vascular | Fase 1 | Reclutando | China | https://ClinicalTrials.gov/show/NCT02433509 |
| NCT03779711 | Síndrome del corazón izquierdo hipoplásico | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03779711 |
| NCT02730299 | Leucemia | Fase 3 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02730299 |
| NCT02730299 | Linfoma | Fase 3 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02730299 |
| NCT02730299 | Mielodisplasia | Fase 3 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02730299 |
| NCT01962636 | Leucemia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01962636 |
| NCT01962636 | Linfoma | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01962636 |
| NCT01962636 | Mieloma | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01962636 |
| NCT01962636 | Mielodisplasia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01962636 |
| NCT03096782 | Leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03096782 |
| NCT03096782 | Linfoma | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03096782 |
| NCT03096782 | Mielodisplasia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03096782 |
| NCT03483324 | Leucemia | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03483324 |
| NCT03483324 | Mielodisplasia | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03483324 |
| NCT01690520 | Leucemia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01690520 |
| NCT01690520 | Linfoma | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01690520 |
| NCT01619761 | Leucemia | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01619761 |
| NCT01619761 | Linfoma | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01619761 |
| NCT01619761 | Mieloma | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01619761 |
| NCT01619761 | Mielodisplasia | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01619761 |
| NCT04013646 | Accidente Cerebro Vascular | Fase 1|Fase 2 | Reclutando | Corea | https://ClinicalTrials.gov/show/NCT04013646 |
| NCT04083170 | Leucemia | Fase 2 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT04083170 |
| NCT04083170 | VIH | Fase 2 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT04083170 |
| NCT04083170 | Mielodisplasia | Fase 2 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT04083170 |
| NCT03979742 | Lesión Medula Espinal | Fase 2 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT03979742 |
| NCT03885947 | Leucemia | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03885947 |
| NCT03885947 | Linfoma | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03885947 |
| NCT03885947 | Mielodisplasia | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03885947 |
| NCT02727803 | Leucemia | N/A | Reclutando | China | https://clinicaltrials.gov/ct2/show/NCT02727803 |
| NCT03016806 | Trastorno hematológico | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03016806 |
| NCT03016806 | Trastorno metabólico | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03016806 |
| NCT03016806 | Anemia | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03016806 |
| NCT02140944 | HIV | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02140944 |
| NCT03835312 | Diabetes Tipo 1 | N/A | Reclutando | China | https://ClinicalTrials.gov/show/NCT03835312 |
| NCT04103879 | Trastornos hematológicos | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT04103879 |
| NCT04393415 | COVID-19 | N/A | No recluta aún | Egipto | https://ClinicalTrials.gov/show/NCT04393415 |
| NCT03011021 | Diabetes Tipo 1 | Fase 1|Fase 2 | Reclutando | China | https://ClinicalTrials.gov/show/NCT03011021 |
| NCT03173937 | Anemia | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03173937 |
| NCT03173937 | Mielodisplasia | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03173937 |
| NCT00719888 | Leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00719888 |
| NCT00719888 | Linfoma | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00719888 |
| NCT00719888 | Mielodisplasia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00719888 |
| NCT00719888 | Anemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00719888 |
| NCT03739502 | Leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03739502 |
| NCT03739502 | Linfoma | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03739502 |
| NCT03739502 | Mielodisplasia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03739502 |
| NCT03826498 | Parálisis cerebral | Fase 2 | Activo, no recluta | Rusia | https://ClinicalTrials.gov/show/NCT03826498 |
| NCT03093844 | Trastorno hematológico | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT03093844 |
| NCT00796068 | Leucemia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00796068 |
| NCT00796068 | Mielodisplasia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00796068 |
| NCT03019640 | Linfoma | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03019640 |
| NCT03558269 | trastorno neonatal | Fase 1|Fase 2 | Reclutando | Israel | https://ClinicalTrials.gov/show/NCT03558269 |
| NCT03558269 | trastorno cardiaco congénito | Fase 1|Fase 2 | Reclutando | Israel | https://ClinicalTrials.gov/show/NCT03558269 |
| NCT01729091 | Leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01729091 |
| NCT01729091 | Mieloma | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01729091 |
| NCT02280525 | Leucemia | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02280525 |
| NCT00547196 | Leucemia | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00547196 |
| NCT00547196 | Linfoma | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00547196 |
| NCT00547196 | Mielodisplasia | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00547196 |
| NCT04099381 | Autismo | Fase 1|Fase 2 | Reclutando | Rusia | https://ClinicalTrials.gov/show/NCT04099381 |
| NCT03056339 | Leucemia | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03056339 |
| NCT03056339 | Linfoma | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03056339 |
| NCT03802773 | Trastorno hematológico | Reclutando | Italia | https://ClinicalTrials.gov/show/NCT03802773 | |
| NCT03594981 | Inmunoterapia antiviral | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03594981 |
| NCT03876821 | Anemia | N/A | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT03876821 |
| NCT03941769 | Leucemia | Fase 1 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT03941769 |
| NCT03941769 | Mielodisplasia | Fase 1 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT03941769 |
| NCT03434730 | Leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03434730 |
| NCT03434730 | Linfoma | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03434730 |
| NCT03434730 | Mielodisplasia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03434730 |
| NCT02508324 | Leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02508324 |
| NCT02508324 | Mielodisplasia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02508324 |
| NCT04003857 | Displasia broncopulmonar | Fase 2 | Reclutando | Corea | https://ClinicalTrials.gov/show/NCT04003857 |
| NCT03420963 | Tumores solidos | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03420963 |
| NCT02722668 | leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02722668 |
| NCT02722668 | Linfoma | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02722668 |
| NCT01927731 | Fallo Medular | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01927731 |
| NCT01632475 | Displasia broncopulmonar | N/A | Activo, no recluta | Corea | https://ClinicalTrials.gov/show/NCT01632475 |
| NCT02254863 | Trastorno metabólico | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02254863 |
| NCT01586455 | Trastorno metabólico | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01586455 |
| NCT00919503 | Trastorno hematológico | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00919503 |
| NCT03773393 | Fallo Medular | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03773393 |
| NCT03773328 | Síndrome Guillain-Barré | Fase 1 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT03773328 |
| NCT03392467 | Displasia broncopulmonar | Fase 2 | Reclutando | Corea | https://ClinicalTrials.gov/show/NCT03392467 |
| NCT03719534 | Trastornos hematológicos | N/A | Reclutando | China | https://ClinicalTrials.gov/show/NCT03719534 |
| NCT00357565 | leucemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00357565 |
| NCT00357565 | Mielodisplasia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00357565 |
| NCT00357565 | Anemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00357565 |
| NCT02046291 | Trastornos hematológicos | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02046291 |
| NCT01590628 | Anemia | Fase 1|Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01590628 |
| NCT01590628 | Talasemia | Fase 1|Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01590628 |
| NCT01962415 | Fallo Medular | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01962415 |
| NCT01962415 | Anemia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01962415 |
| NCT01962415 | Trastorno metabólico | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01962415 |
| NCT00408447 | Anemia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00408447 |
| NCT00408447 | Talasemia | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00408447 |
| NCT03406962 | Trastorno metabólico | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT03406962 |
| NCT03158896 | Injerto contra huésped (GVHD) | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT03158896 |
| NCT04098029 | Parálisis cerebral | Fase 2 | Reclutando | Rusia | https://ClinicalTrials.gov/show/NCT04098029 |
| NCT03634501 | Tumores solidos | Fase 1|Fase 2 | Reclutando | China | https://ClinicalTrials.gov/show/NCT03634501 |
| NCT01810588 | Trastornos hematológicos | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01810588 |
| NCT04260698 | Trastornos hematológicos | Fase 3 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT04260698 |
| NCT04324996 | COVID-19 | Fase 1|Fase 2 | Reclutando | China | https://ClinicalTrials.gov/show/NCT04324996 |
| NCT04418557 | COVID-19 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT04418557 | |
| NCT02251821 | Mielofibrosis | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02251821 |
| NCT03635450 | Encefalopatía hipóxico-isquémica | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT03635450 |
| NCT04379284 | COVID-19 | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT04379284 | |
| NCT00012545 | Anemia | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT00012545 | |
| NCT04360811 | COVID-19 | N/A | Reclutando | Francia | https://ClinicalTrials.gov/show/NCT04360811 |
| NCT01020539 | Leucemia | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01020539 |
| NCT01020539 | Mielodisplasia | Fase 1 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01020539 |
| NCT03378063 | Displasia broncopulmonar | Fase temprana 1 | Reclutando | China | https://ClinicalTrials.gov/show/NCT03378063 |
| NCT04347616 | Leucemia | Fase 1|Fase 2 | No recluta aún | Holanda | https://ClinicalTrials.gov/show/NCT04347616 |
| NCT01174875 | Trastorno Mental | N/A | Activo, no recluta | Singapur | https://ClinicalTrials.gov/show/NCT01174875 |
| NCT01174875 | Trastorno Metabólico | N/A | Activo, no recluta | Singapur | https://ClinicalTrials.gov/show/NCT01174875 |
| NCT02065596 | Anemia | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02065596 |
| NCT01050855 | Inmunodeficiencia | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01050855 |
| NCT04140747 | Colonización Microbiana | N/A | Reclutando | Austria | https://ClinicalTrials.gov/show/NCT04140747 |
| NCT02184676 | Diabetes Tipo 1 | N/A | Activo, no recluta | Francia | https://ClinicalTrials.gov/show/NCT02184676 |
| NCT04213131 | Lesión Medula Espinal | N/A | Reclutando | China | https://ClinicalTrials.gov/show/NCT04213131 |
| NCT02179359 | Anemia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02179359 |
| NCT02179359 | Síndrome Shwachman-Diamond | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02179359 |
| NCT02179359 | Talasemia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02179359 |
| NCT02179359 | Trombastenia de Glanzmann | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02179359 |
| NCT02179359 | Fallo Medular | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02179359 |
| NCT03904134 | Leucemia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03904134 |
| NCT03904134 | Linfoma | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03904134 |
| NCT03904134 | Anemia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03904134 |
| NCT00574496 | Linfoma | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00574496 |
| NCT03513328 | Trastorno Hereditario | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03513328 |
| NCT03513328 | Anemia | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03513328 |
| NCT03513328 | Fallo Medular | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03513328 |
| NCT03513328 | Talasemia | Fase 1|Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03513328 |
| NCT01033552 | Epidermólisis Bullosa | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01033552 |
| NCT01366092 | Enfermedad injerto contra Huésped (GVHD) | Fase 2 | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT01366092 |
| NCT03393611 | Leucemia | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03393611 |
| NCT03393611 | Mielodisplasia | Fase 1 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03393611 |
| NCT01685411 | Leucemia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01685411 |
| NCT01685411 | Mielodisplasia | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01685411 |
| NCT04008849 | Desorden Metabólico | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT04008849 |
| NCT04353544 | Hemorragia post parto | N/A | Reclutando | Italia | https://ClinicalTrials.gov/show/NCT04353544 |
| NCT01652092 | Trastorno Hereditario | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT01652092 |
| NCT04369313 | Diabetes Tipo 1 | N/A | Reclutando | China | https://ClinicalTrials.gov/show/NCT04369313 |
| NCT04369313 | Asfixia neonatal | N/A | Reclutando | China | https://ClinicalTrials.gov/show/NCT04369313 |
| NCT02878850 | Lesión Medula Espinal | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02878850 |
| NCT04395924 | COVID-19 | Reclutando | Francia | https://ClinicalTrials.gov/show/NCT04395924 | |
| NCT00913471 | Lesión Medula Espinal | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT00913471 |
| NCT02396823 | Lesión Medula Espinal | N/A | Activo, no recluta | Estados Unidos | https://ClinicalTrials.gov/show/NCT02396823 |
| NCT03949660 | Disfunción intestinal neurógena | N/A | No recluta aún | Estados Unidos | https://ClinicalTrials.gov/show/NCT03949660 |
| NCT03681314 | Encefalopatía hipóxico-isquémica | N/A | No recluta aún | India | https://ClinicalTrials.gov/show/NCT03681314 |
| NCT03682042 | Encefalopatía hipóxico-isquémica | N/A | No recluta aún | India | https://ClinicalTrials.gov/show/NCT03682042 |
| NCT02893553 | Lesión Medula Espinal | Fase 2 | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT02893553 |
| NCT03621943 | Trastorno neuronal | N/A | Reclutando | Canadá | https://ClinicalTrials.gov/show/NCT03621943 |
| NCT03690700 | Lesión Medula Espinal | N/A | No recluta aún | Dinamarca | https://ClinicalTrials.gov/show/NCT03690700 |
| NCT03621956 | Asfixia neonatal | N/A | Reclutando | Canadá | https://ClinicalTrials.gov/show/NCT03621956 |
| NCT03505463 | Lesión Medula Espinal | N/A | Reclutando | Dinamarca | https://ClinicalTrials.gov/show/NCT03505463 |
| NCT03657394 | Encefalopatía hipóxico-isquémica | Fase 3 | No recluta aún | India | https://ClinicalTrials.gov/show/NCT03657394 |
| NCT03998527 | Lesión Medula Espinal | N/A | Reclutando | Estados Unidos | https://ClinicalTrials.gov/show/NCT03998527 |
| NCT02859792 | Lesión Medula Espinal | Fase 2 | No recluta aún | Francia | https://ClinicalTrials.gov/show/NCT02859792 |
| NCT04687657 | Leucemia | Fase 1 | No reclutando | China | https://ClinicalTrials.gov/show/NCT04687657 |
| NCT04768816 | Autismo | Fase 1 | Reclutando | China | https://clinicaltrials.gov/ct2/show/NCT04768816 |
| NCT04566757 | Daño cerebral | Fase 1 | No Reclutando | USA | https://ClinicalTrials.gov/show/NCT04566757 |
| NCT04174586 | Leucemia mieloide | Fase 1 | Reclutando | China | https://ClinicalTrials.gov/show/NCT04174586 |
| NCT04636853 | Retinitis Pigmentosa | Fase 3 | Reclutando | Italia | https://ClinicalTrials.gov/show/NCT04636853 |
| NCT04689425 | Pie Diabético | Fase 3 | No Reclutando | China | https://ClinicalTrials.gov/show/NCT04689425 |
| NCT04594031 | Anemia | Fase 1 | No reclutando | USA | https://ClinicalTrials.gov/show/NCT04594031 |
| NCT04710810 | Autismo | Fase 1 | No reclutando | China | https://ClinicalTrials.gov/show/NCT03791372 |
| NCT04644016 | Leucemia | Fase 2 | Reclutando | USA | https://ClinicalTrials.gov/show/NCT04644016 |
| NCT04707300 | Leucemia mieloide | Fase 1/Fase 2 | No reclutando | Francia | https://ClinicalTrials.gov/show/NCT04707300 |
| NCT04393415 | Covid-19 | N/A | Reclutando | Egipto | https://ClinicalTrials.gov/show/NCT04393415 |
| NCT04632316 | Leucemia mieloide | Fase 1/Fase 2 | Reclutando | Varios | https://ClinicalTrials.gov/show/NCT04632316 |
| NCT02039557 | Expansión celular | N/A | No reclutando | USA | https://ClinicalTrials.gov/show/NCT02039557 |
| NCT03441958 | Expansión celular | Fase 1/Fase 2 | Reclutando | Canadá | https://ClinicalTrials.gov/show/NCT03441958 |
| NCT03913026 | Expansión celular | Fase 2 | Reclutando | Canadá | https://ClinicalTrials.gov/show/NCT03913026 |
| NCT03791372 | Parálisis Cerebral | Fase 1 | Reclutando | China | https://ClinicalTrials.gov/show/NCT03791372 |
